1.20Open1.20Pre Close0 Volume1 Open Interest2.50Strike Price0.00Turnover274.59%IV10.96%PremiumAug 16, 2024Expiry Date1.04Intrinsic Value100Multiplier23DDays to Expiry0.16Extrinsic Value100Contract SizeAmericanOptions Type-0.6589Delta0.3592Gamma1.22Leverage Ratio-0.0076Theta-0.0012Rho-0.80Eff Leverage0.0014Vega
Immunic Stock Discussion
$Taysha Gene Therapies(TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US)$ 14% Clinical programs update
$Jaguar Health(JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US)$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US)$ 0...
PR Newswire· 1 min ago
get the lead out 😜
No comment yet